María Victoria
Mateos Manteca
Addenbrooke's Hospital
Cambridge, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von Addenbrooke's Hospital (1)
2023
-
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 4, pp. 711-722